Michael Knierman

Michael is currently a senior research scientist with Eli Lilly and Co, Indianapolis, Indiana, USA). His laboratory works on top down proteomics with high resolution mass spectrometry, informatics for proteomics, identification of protein modifications, protein chemistry, and biomarker, and drug target discovery and validation. He currently has three CE-MS systems in his lab and is working on improvements for the technology.